 Sachin Wani
Concepts (612)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 103 | 2025 | 149 | 31.490 |
Why?
| | Esophageal Neoplasms | 77 | 2024 | 324 | 20.600 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 44 | 2025 | 211 | 10.610 |
Why?
| | Adenocarcinoma | 62 | 2024 | 936 | 10.500 |
Why?
| | Esophagoscopy | 54 | 2024 | 209 | 9.620 |
Why?
| | Endosonography | 38 | 2024 | 156 | 9.430 |
Why?
| | Gastroenterology | 29 | 2025 | 181 | 8.710 |
Why?
| | Endoscopy, Gastrointestinal | 42 | 2024 | 227 | 8.090 |
Why?
| | Endoscopy, Digestive System | 24 | 2023 | 136 | 6.980 |
Why?
| | Precancerous Conditions | 28 | 2023 | 169 | 6.960 |
Why?
| | Colonoscopy | 33 | 2025 | 247 | 6.440 |
Why?
| | Quality Indicators, Health Care | 19 | 2024 | 308 | 6.430 |
Why?
| | Colonic Polyps | 22 | 2025 | 88 | 5.890 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 19 | 2024 | 56 | 5.230 |
Why?
| | Clinical Competence | 28 | 2025 | 1093 | 4.660 |
Why?
| | Gastroesophageal Reflux | 19 | 2023 | 234 | 4.640 |
Why?
| | Esophagus | 21 | 2021 | 255 | 4.010 |
Why?
| | Pancreatic Neoplasms | 23 | 2024 | 931 | 3.400 |
Why?
| | Learning Curve | 13 | 2024 | 72 | 3.250 |
Why?
| | Endoscopic Mucosal Resection | 11 | 2024 | 24 | 3.030 |
Why?
| | Pancreatitis | 16 | 2025 | 132 | 2.880 |
Why?
| | Adenoma | 17 | 2023 | 230 | 2.840 |
Why?
| | Population Surveillance | 12 | 2024 | 470 | 2.830 |
Why?
| | Gastrointestinal Diseases | 9 | 2022 | 209 | 2.750 |
Why?
| | Humans | 294 | 2025 | 136783 | 2.500 |
Why?
| | Endoscopy | 15 | 2021 | 316 | 2.460 |
Why?
| | Biopsy | 23 | 2023 | 1126 | 2.130 |
Why?
| | Cholangitis | 6 | 2024 | 20 | 2.000 |
Why?
| | Colorectal Neoplasms | 14 | 2023 | 792 | 1.950 |
Why?
| | Stents | 17 | 2025 | 528 | 1.920 |
Why?
| | Pancreatic Cyst | 4 | 2020 | 60 | 1.870 |
Why?
| | Watchful Waiting | 8 | 2021 | 80 | 1.720 |
Why?
| | Guideline Adherence | 5 | 2021 | 543 | 1.690 |
Why?
| | Catheter Ablation | 8 | 2022 | 349 | 1.680 |
Why?
| | Narrow Band Imaging | 8 | 2022 | 14 | 1.640 |
Why?
| | Prospective Studies | 46 | 2024 | 7583 | 1.640 |
Why?
| | Societies, Medical | 9 | 2024 | 820 | 1.610 |
Why?
| | Fellowships and Scholarships | 5 | 2024 | 306 | 1.590 |
Why?
| | Sphincterotomy, Endoscopic | 10 | 2024 | 28 | 1.530 |
Why?
| | Bile Duct Neoplasms | 4 | 2021 | 123 | 1.460 |
Why?
| | Pancreatic Diseases | 10 | 2020 | 72 | 1.420 |
Why?
| | Education, Medical, Graduate | 8 | 2024 | 481 | 1.420 |
Why?
| | Hyperplasia | 8 | 2024 | 175 | 1.380 |
Why?
| | Disease Progression | 20 | 2023 | 2750 | 1.340 |
Why?
| | Middle Aged | 95 | 2025 | 33200 | 1.270 |
Why?
| | Fiducial Markers | 2 | 2019 | 9 | 1.260 |
Why?
| | Aged | 77 | 2025 | 23729 | 1.250 |
Why?
| | Pancreas | 10 | 2024 | 328 | 1.220 |
Why?
| | Gastrointestinal Neoplasms | 3 | 2024 | 77 | 1.190 |
Why?
| | United States | 40 | 2025 | 14660 | 1.140 |
Why?
| | Male | 110 | 2025 | 67361 | 1.110 |
Why?
| | Registries | 8 | 2022 | 2015 | 1.080 |
Why?
| | Needles | 5 | 2024 | 59 | 1.070 |
Why?
| | Ampulla of Vater | 4 | 2023 | 42 | 1.070 |
Why?
| | Choledocholithiasis | 3 | 2023 | 16 | 1.040 |
Why?
| | Female | 107 | 2025 | 72840 | 1.040 |
Why?
| | Ablation Techniques | 4 | 2024 | 36 | 1.040 |
Why?
| | Benchmarking | 4 | 2022 | 183 | 1.020 |
Why?
| | Esophagitis, Peptic | 3 | 2023 | 15 | 1.010 |
Why?
| | Esophagectomy | 7 | 2023 | 131 | 1.010 |
Why?
| | Catheterization | 9 | 2024 | 179 | 1.000 |
Why?
| | Biopsy, Fine-Needle | 4 | 2017 | 68 | 0.990 |
Why?
| | Esophageal Achalasia | 3 | 2021 | 30 | 0.980 |
Why?
| | Rectum | 2 | 2019 | 185 | 0.980 |
Why?
| | Intestinal Polyps | 2 | 2016 | 17 | 0.980 |
Why?
| | Digestive System Diseases | 3 | 2015 | 26 | 0.950 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2024 | 132 | 0.930 |
Why?
| | Aptitude | 2 | 2015 | 39 | 0.920 |
Why?
| | Biliary Tract Diseases | 5 | 2020 | 39 | 0.910 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2021 | 15 | 0.910 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1294 | 0.900 |
Why?
| | Pepsin A | 2 | 2021 | 19 | 0.900 |
Why?
| | Self-Assessment | 1 | 2025 | 74 | 0.900 |
Why?
| | Observer Variation | 13 | 2017 | 345 | 0.890 |
Why?
| | Self Expandable Metallic Stents | 2 | 2021 | 16 | 0.890 |
Why?
| | Pancreatic Ducts | 7 | 2024 | 85 | 0.880 |
Why?
| | Margins of Excision | 1 | 2024 | 50 | 0.870 |
Why?
| | Lymph Nodes | 4 | 2015 | 492 | 0.860 |
Why?
| | Taurine | 1 | 2023 | 46 | 0.840 |
Why?
| | Colonic Pseudo-Obstruction | 2 | 2020 | 4 | 0.830 |
Why?
| | Neoplasm Staging | 8 | 2024 | 1373 | 0.830 |
Why?
| | Practice Guidelines as Topic | 11 | 2021 | 1568 | 0.820 |
Why?
| | Intestinal Volvulus | 2 | 2020 | 15 | 0.820 |
Why?
| | Time-to-Treatment | 1 | 2024 | 203 | 0.800 |
Why?
| | Early Detection of Cancer | 13 | 2024 | 419 | 0.790 |
Why?
| | Drainage | 8 | 2024 | 168 | 0.790 |
Why?
| | Incidence | 19 | 2025 | 2788 | 0.770 |
Why?
| | Disease Management | 3 | 2021 | 623 | 0.770 |
Why?
| | Treatment Outcome | 29 | 2025 | 10764 | 0.770 |
Why?
| | Stomach Diseases | 2 | 2014 | 20 | 0.760 |
Why?
| | Cholestasis | 3 | 2021 | 232 | 0.750 |
Why?
| | Rectal Diseases | 2 | 2019 | 23 | 0.750 |
Why?
| | Endoscopes | 2 | 2021 | 17 | 0.730 |
Why?
| | Teaching Rounds | 1 | 2022 | 67 | 0.730 |
Why?
| | Deglutition Disorders | 2 | 2021 | 143 | 0.720 |
Why?
| | Equipment Reuse | 1 | 2021 | 16 | 0.700 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2021 | 14 | 0.700 |
Why?
| | Referral and Consultation | 4 | 2024 | 777 | 0.700 |
Why?
| | Esophageal Diseases | 2 | 2014 | 28 | 0.700 |
Why?
| | Dilatation | 3 | 2019 | 65 | 0.700 |
Why?
| | Pancreatectomy | 3 | 2021 | 252 | 0.690 |
Why?
| | Argon Plasma Coagulation | 1 | 2020 | 6 | 0.690 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2023 | 1055 | 0.690 |
Why?
| | Hemostasis, Endoscopic | 1 | 2020 | 1 | 0.680 |
Why?
| | Retrospective Studies | 36 | 2025 | 15564 | 0.680 |
Why?
| | Sensitivity and Specificity | 19 | 2023 | 1942 | 0.680 |
Why?
| | Competency-Based Education | 2 | 2024 | 74 | 0.680 |
Why?
| | Delphi Technique | 6 | 2024 | 273 | 0.670 |
Why?
| | Gastrointestinal Stromal Tumors | 2 | 2017 | 38 | 0.670 |
Why?
| | Heller Myotomy | 1 | 2019 | 2 | 0.660 |
Why?
| | Acetylcholine Release Inhibitors | 1 | 2019 | 4 | 0.660 |
Why?
| | Sigmoid Diseases | 1 | 2019 | 12 | 0.660 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 27 | 0.650 |
Why?
| | Cholinesterase Inhibitors | 1 | 2019 | 30 | 0.640 |
Why?
| | SEER Program | 4 | 2020 | 218 | 0.640 |
Why?
| | Proctoscopy | 1 | 2019 | 6 | 0.640 |
Why?
| | Bile Ducts | 3 | 2014 | 71 | 0.640 |
Why?
| | Conservative Treatment | 1 | 2019 | 32 | 0.630 |
Why?
| | Botulinum Toxins | 1 | 2019 | 41 | 0.630 |
Why?
| | Medical Overuse | 1 | 2019 | 30 | 0.630 |
Why?
| | Carcinoma | 3 | 2021 | 236 | 0.620 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 36 | 0.620 |
Why?
| | Quality of Health Care | 2 | 2021 | 627 | 0.620 |
Why?
| | Decompression, Surgical | 1 | 2019 | 97 | 0.620 |
Why?
| | Risk Factors | 22 | 2025 | 10331 | 0.610 |
Why?
| | Racism | 1 | 2021 | 135 | 0.600 |
Why?
| | Colonic Neoplasms | 7 | 2022 | 256 | 0.600 |
Why?
| | Acute Disease | 8 | 2024 | 1006 | 0.590 |
Why?
| | Stomach Neoplasms | 4 | 2024 | 124 | 0.580 |
Why?
| | Family Health | 1 | 2019 | 197 | 0.580 |
Why?
| | Conflict of Interest | 1 | 2020 | 127 | 0.570 |
Why?
| | Intestinal Perforation | 2 | 2016 | 46 | 0.570 |
Why?
| | Radiation Injuries | 1 | 2019 | 145 | 0.570 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 179 | 0.560 |
Why?
| | Adult | 47 | 2025 | 37616 | 0.560 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 154 | 0.560 |
Why?
| | Cytological Techniques | 1 | 2017 | 27 | 0.550 |
Why?
| | Time Factors | 14 | 2025 | 6792 | 0.550 |
Why?
| | Cathartics | 1 | 2016 | 15 | 0.520 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 322 | 0.520 |
Why?
| | Metaplasia | 10 | 2023 | 60 | 0.520 |
Why?
| | Documentation | 2 | 2023 | 189 | 0.520 |
Why?
| | Cohort Studies | 10 | 2023 | 5718 | 0.520 |
Why?
| | Carcinoembryonic Antigen | 2 | 2018 | 39 | 0.510 |
Why?
| | Diagnostic Tests, Routine | 1 | 2017 | 109 | 0.510 |
Why?
| | Conscious Sedation | 2 | 2020 | 91 | 0.510 |
Why?
| | Diarrhea | 3 | 2019 | 183 | 0.510 |
Why?
| | Specimen Handling | 1 | 2017 | 178 | 0.500 |
Why?
| | Hospitals | 1 | 2021 | 677 | 0.500 |
Why?
| | Indomethacin | 3 | 2025 | 81 | 0.500 |
Why?
| | Aged, 80 and over | 22 | 2025 | 7569 | 0.500 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 27 | 0.490 |
Why?
| | Adenomatous Polyps | 1 | 2015 | 10 | 0.490 |
Why?
| | Liver Neoplasms | 4 | 2024 | 784 | 0.490 |
Why?
| | Hypnotics and Sedatives | 2 | 2020 | 199 | 0.480 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 2015 | 13 | 0.480 |
Why?
| | Cystadenoma, Mucinous | 1 | 2015 | 13 | 0.480 |
Why?
| | Quality Improvement | 2 | 2021 | 1152 | 0.480 |
Why?
| | Pathology, Clinical | 1 | 2015 | 36 | 0.480 |
Why?
| | Predictive Value of Tests | 17 | 2019 | 2030 | 0.470 |
Why?
| | Jaundice, Obstructive | 1 | 2014 | 2 | 0.470 |
Why?
| | Ultrasonography, Interventional | 2 | 2019 | 142 | 0.470 |
Why?
| | Duodenal Diseases | 1 | 2014 | 8 | 0.460 |
Why?
| | Carcinoma, Squamous Cell | 4 | 2014 | 682 | 0.460 |
Why?
| | Aftercare | 4 | 2023 | 209 | 0.460 |
Why?
| | Neoplasms | 3 | 2020 | 2644 | 0.450 |
Why?
| | Pancreaticoduodenectomy | 1 | 2016 | 163 | 0.450 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 34 | 0.450 |
Why?
| | Colectomy | 1 | 2015 | 100 | 0.440 |
Why?
| | Mucous Membrane | 9 | 2015 | 125 | 0.440 |
Why?
| | Duodenum | 1 | 2014 | 77 | 0.440 |
Why?
| | Curriculum | 2 | 2024 | 979 | 0.440 |
Why?
| | Hemorrhage | 4 | 2020 | 723 | 0.440 |
Why?
| | Advisory Committees | 5 | 2014 | 219 | 0.430 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 620 | 0.430 |
Why?
| | Recurrence | 4 | 2024 | 1058 | 0.430 |
Why?
| | Cholecystectomy | 3 | 2019 | 60 | 0.430 |
Why?
| | Delivery of Health Care | 1 | 2021 | 939 | 0.420 |
Why?
| | Internship and Residency | 3 | 2021 | 1131 | 0.420 |
Why?
| | Multimodal Imaging | 1 | 2014 | 116 | 0.420 |
Why?
| | Precision Medicine | 1 | 2017 | 426 | 0.420 |
Why?
| | Risk Assessment | 10 | 2020 | 3429 | 0.420 |
Why?
| | Tomography, X-Ray Computed | 6 | 2020 | 2677 | 0.410 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.410 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2012 | 10 | 0.400 |
Why?
| | Educational Measurement | 4 | 2025 | 280 | 0.400 |
Why?
| | Education, Medical, Continuing | 3 | 2022 | 125 | 0.400 |
Why?
| | Positron-Emission Tomography | 1 | 2014 | 295 | 0.400 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 78 | 0.400 |
Why?
| | Enteral Nutrition | 3 | 2021 | 200 | 0.390 |
Why?
| | Reproducibility of Results | 16 | 2023 | 3272 | 0.390 |
Why?
| | Health Care Costs | 1 | 2015 | 385 | 0.390 |
Why?
| | Osteitis Deformans | 2 | 2023 | 6 | 0.390 |
Why?
| | Cholecystitis | 3 | 2024 | 24 | 0.390 |
Why?
| | Gastroenterologists | 2 | 2022 | 18 | 0.390 |
Why?
| | Logistic Models | 8 | 2024 | 2060 | 0.380 |
Why?
| | Multivariate Analysis | 7 | 2021 | 1513 | 0.380 |
Why?
| | Pancreatitis, Chronic | 3 | 2024 | 58 | 0.380 |
Why?
| | Cholangiocarcinoma | 1 | 2013 | 104 | 0.370 |
Why?
| | Pandemics | 6 | 2023 | 1619 | 0.370 |
Why?
| | Manometry | 3 | 2021 | 95 | 0.360 |
Why?
| | Laparoscopy | 1 | 2015 | 464 | 0.350 |
Why?
| | Neuroendocrine Tumors | 3 | 2018 | 115 | 0.350 |
Why?
| | Postoperative Complications | 5 | 2024 | 2624 | 0.350 |
Why?
| | Propofol | 1 | 2011 | 73 | 0.350 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 368 | 0.350 |
Why?
| | Myotomy | 2 | 2021 | 13 | 0.350 |
Why?
| | Coronavirus Infections | 3 | 2020 | 359 | 0.350 |
Why?
| | Video Recording | 7 | 2019 | 181 | 0.350 |
Why?
| | Sex Factors | 5 | 2021 | 2068 | 0.350 |
Why?
| | Hypotension | 1 | 2011 | 122 | 0.340 |
Why?
| | Consensus | 4 | 2024 | 679 | 0.340 |
Why?
| | Pathology, Surgical | 1 | 2010 | 10 | 0.340 |
Why?
| | Evidence-Based Medicine | 6 | 2024 | 738 | 0.340 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 22 | 0.330 |
Why?
| | Education, Medical | 1 | 2013 | 260 | 0.320 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2019 | 12 | 0.320 |
Why?
| | Informed Consent | 3 | 2022 | 169 | 0.310 |
Why?
| | Irritable Bowel Syndrome | 2 | 2019 | 26 | 0.310 |
Why?
| | Hernia, Hiatal | 4 | 2021 | 35 | 0.310 |
Why?
| | Wandering Spleen | 1 | 2008 | 2 | 0.310 |
Why?
| | Odds Ratio | 4 | 2018 | 1063 | 0.310 |
Why?
| | Histocytochemistry | 4 | 2013 | 79 | 0.300 |
Why?
| | Computer-Assisted Instruction | 4 | 2024 | 65 | 0.300 |
Why?
| | Survival Rate | 3 | 2021 | 1969 | 0.300 |
Why?
| | Image Enhancement | 6 | 2018 | 190 | 0.290 |
Why?
| | Surgeons | 2 | 2022 | 296 | 0.290 |
Why?
| | Tertiary Care Centers | 4 | 2016 | 160 | 0.280 |
Why?
| | Microscopy, Confocal | 5 | 2020 | 322 | 0.280 |
Why?
| | Decision Trees | 2 | 2019 | 94 | 0.280 |
Why?
| | Proton Pump Inhibitors | 3 | 2022 | 108 | 0.270 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 3 | 2025 | 350 | 0.270 |
Why?
| | Malignant Catarrh | 1 | 2006 | 1 | 0.270 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2024 | 360 | 0.270 |
Why?
| | Goats | 1 | 2006 | 27 | 0.270 |
Why?
| | Sphincter of Oddi | 3 | 2024 | 5 | 0.260 |
Why?
| | Herpesviridae | 1 | 2006 | 23 | 0.260 |
Why?
| | Liver Transplantation | 1 | 2014 | 871 | 0.260 |
Why?
| | Fluid Therapy | 2 | 2018 | 147 | 0.260 |
Why?
| | Mass Screening | 5 | 2022 | 1262 | 0.260 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 24 | 0.260 |
Why?
| | Age Factors | 5 | 2020 | 3290 | 0.260 |
Why?
| | Picolinic Acids | 1 | 2006 | 9 | 0.250 |
Why?
| | Obesity | 4 | 2019 | 2975 | 0.250 |
Why?
| | Carrier State | 1 | 2006 | 65 | 0.250 |
Why?
| | Kidney Tubular Necrosis, Acute | 1 | 2006 | 26 | 0.250 |
Why?
| | Prevalence | 7 | 2023 | 2712 | 0.250 |
Why?
| | Natural Orifice Endoscopic Surgery | 3 | 2021 | 34 | 0.250 |
Why?
| | Lithotripsy | 3 | 2024 | 48 | 0.240 |
Why?
| | Pancreatic Pseudocyst | 3 | 2024 | 17 | 0.240 |
Why?
| | Follow-Up Studies | 10 | 2015 | 5115 | 0.240 |
Why?
| | Decision Support Techniques | 3 | 2019 | 418 | 0.240 |
Why?
| | Feasibility Studies | 6 | 2024 | 947 | 0.230 |
Why?
| | Singapore | 1 | 2025 | 22 | 0.230 |
Why?
| | Sphincter of Oddi Dysfunction | 1 | 2024 | 1 | 0.230 |
Why?
| | Osteoclasts | 3 | 2023 | 52 | 0.230 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 285 | 0.230 |
Why?
| | Diagnosis, Differential | 6 | 2019 | 1483 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2005 | 24 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 3 | 2022 | 2417 | 0.230 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.230 |
Why?
| | Constriction, Pathologic | 5 | 2020 | 241 | 0.230 |
Why?
| | DNA, Viral | 1 | 2006 | 362 | 0.220 |
Why?
| | Hypoxia | 1 | 2011 | 1107 | 0.220 |
Why?
| | Escherichia coli Infections | 1 | 2005 | 111 | 0.220 |
Why?
| | Program Evaluation | 2 | 2020 | 886 | 0.220 |
Why?
| | Sheep | 1 | 2006 | 855 | 0.210 |
Why?
| | Bile Duct Diseases | 2 | 2014 | 14 | 0.210 |
Why?
| | Common Bile Duct Neoplasms | 1 | 2023 | 30 | 0.210 |
Why?
| | Postoperative Hemorrhage | 1 | 2024 | 87 | 0.210 |
Why?
| | G-Protein-Coupled Receptor Kinase 3 | 1 | 2023 | 2 | 0.210 |
Why?
| | Kaplan-Meier Estimate | 3 | 2020 | 891 | 0.210 |
Why?
| | Ergonomics | 1 | 2023 | 25 | 0.210 |
Why?
| | Pancreatitis, Acute Necrotizing | 1 | 2023 | 13 | 0.210 |
Why?
| | Cytodiagnosis | 2 | 2020 | 33 | 0.200 |
Why?
| | Cholelithiasis | 1 | 2023 | 37 | 0.200 |
Why?
| | Microsurgery | 1 | 2023 | 75 | 0.200 |
Why?
| | Carcinoid Tumor | 1 | 2022 | 26 | 0.200 |
Why?
| | Medicare | 2 | 2021 | 747 | 0.200 |
Why?
| | Appendiceal Neoplasms | 1 | 2022 | 27 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 99 | 0.200 |
Why?
| | Bone Resorption | 1 | 2023 | 86 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 193 | 0.190 |
Why?
| | Fluorouracil | 1 | 2023 | 210 | 0.190 |
Why?
| | Bone Diseases, Metabolic | 1 | 2023 | 62 | 0.190 |
Why?
| | Forecasting | 1 | 2024 | 384 | 0.190 |
Why?
| | Biomedical Research | 2 | 2020 | 689 | 0.190 |
Why?
| | Surgical Instruments | 3 | 2022 | 52 | 0.190 |
Why?
| | Gastrectomy | 2 | 2023 | 123 | 0.190 |
Why?
| | Health Care Surveys | 3 | 2020 | 563 | 0.190 |
Why?
| | Diverticulum, Esophageal | 1 | 2021 | 4 | 0.190 |
Why?
| | Weight Loss | 2 | 2021 | 775 | 0.190 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.180 |
Why?
| | Aspirin | 1 | 2025 | 384 | 0.180 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.180 |
Why?
| | Biopsy, Needle | 2 | 2020 | 189 | 0.180 |
Why?
| | Disease Outbreaks | 1 | 2005 | 382 | 0.180 |
Why?
| | Professional Practice Location | 2 | 2019 | 29 | 0.180 |
Why?
| | Dietary Supplements | 1 | 2006 | 559 | 0.180 |
Why?
| | Single-Blind Method | 5 | 2014 | 286 | 0.180 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2021 | 14 | 0.180 |
Why?
| | Trefoil Factor-3 | 1 | 2020 | 5 | 0.180 |
Why?
| | Internationality | 2 | 2020 | 155 | 0.180 |
Why?
| | Gastric Outlet Obstruction | 1 | 2020 | 11 | 0.170 |
Why?
| | Formative Feedback | 2 | 2024 | 28 | 0.170 |
Why?
| | Oral Submucous Fibrosis | 1 | 2020 | 2 | 0.170 |
Why?
| | Radiography, Abdominal | 2 | 2012 | 45 | 0.170 |
Why?
| | Midazolam | 1 | 2020 | 56 | 0.170 |
Why?
| | Escherichia coli | 1 | 2005 | 812 | 0.170 |
Why?
| | Digestive System Surgical Procedures | 1 | 2021 | 106 | 0.170 |
Why?
| | Equipment Contamination | 1 | 2021 | 63 | 0.170 |
Why?
| | Stomach | 2 | 2012 | 110 | 0.170 |
Why?
| | Betacoronavirus | 2 | 2020 | 267 | 0.170 |
Why?
| | Varicose Veins | 1 | 2020 | 17 | 0.170 |
Why?
| | Laparotomy | 2 | 2012 | 109 | 0.170 |
Why?
| | Cost-Benefit Analysis | 3 | 2015 | 584 | 0.170 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.170 |
Why?
| | Emergencies | 1 | 2021 | 164 | 0.170 |
Why?
| | Hospitalization | 3 | 2025 | 2195 | 0.170 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 40 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2021 | 3537 | 0.160 |
Why?
| | Neostigmine | 1 | 2019 | 7 | 0.160 |
Why?
| | Morbidity | 1 | 2021 | 322 | 0.160 |
Why?
| | Cecum | 1 | 2019 | 33 | 0.160 |
Why?
| | Body Fluids | 1 | 2020 | 66 | 0.160 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 34 | 0.160 |
Why?
| | Colostomy | 1 | 2019 | 28 | 0.160 |
Why?
| | Perception | 1 | 2022 | 356 | 0.160 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 61 | 0.160 |
Why?
| | Accreditation | 1 | 2020 | 83 | 0.160 |
Why?
| | Survival Analysis | 2 | 2015 | 1319 | 0.160 |
Why?
| | Dissection | 2 | 2020 | 52 | 0.160 |
Why?
| | Mirizzi Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Disinfection | 1 | 2021 | 122 | 0.160 |
Why?
| | Injections, Intramuscular | 1 | 2019 | 126 | 0.160 |
Why?
| | ROC Curve | 4 | 2015 | 545 | 0.160 |
Why?
| | Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| | Research Design | 2 | 2020 | 1107 | 0.160 |
Why?
| | Saliva | 1 | 2021 | 241 | 0.160 |
Why?
| | India | 3 | 2018 | 193 | 0.160 |
Why?
| | Ascites | 1 | 2019 | 46 | 0.160 |
Why?
| | Anastomotic Leak | 1 | 2019 | 41 | 0.150 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2020 | 317 | 0.150 |
Why?
| | Feedback | 1 | 2019 | 173 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2023 | 258 | 0.150 |
Why?
| | Mastitis, Bovine | 1 | 2018 | 2 | 0.150 |
Why?
| | Chronic Disease | 3 | 2019 | 1784 | 0.150 |
Why?
| | Infection Control | 1 | 2020 | 158 | 0.150 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.150 |
Why?
| | Phage Therapy | 1 | 2018 | 15 | 0.150 |
Why?
| | Fluoroscopy | 1 | 2019 | 157 | 0.150 |
Why?
| | Plastics | 2 | 2018 | 48 | 0.150 |
Why?
| | Esophagogastric Junction | 3 | 2021 | 51 | 0.150 |
Why?
| | Gallstones | 1 | 2018 | 31 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2019 | 268 | 0.140 |
Why?
| | Colonoscopes | 3 | 2014 | 5 | 0.140 |
Why?
| | Health Status Disparities | 1 | 2021 | 284 | 0.140 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 21 | 0.140 |
Why?
| | Quality-Adjusted Life Years | 2 | 2015 | 112 | 0.140 |
Why?
| | Markov Chains | 2 | 2015 | 122 | 0.140 |
Why?
| | Mortality | 1 | 2020 | 357 | 0.140 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2017 | 20 | 0.140 |
Why?
| | Reference Standards | 1 | 2018 | 183 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2018 | 48 | 0.140 |
Why?
| | Cardia | 2 | 2007 | 2 | 0.140 |
Why?
| | Palliative Care | 2 | 2021 | 743 | 0.140 |
Why?
| | Prognosis | 3 | 2017 | 4018 | 0.140 |
Why?
| | Anti-Bacterial Agents | 2 | 2018 | 1799 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2020 | 272 | 0.140 |
Why?
| | Medical Staff Privileges | 1 | 2017 | 5 | 0.140 |
Why?
| | Education | 1 | 2017 | 106 | 0.130 |
Why?
| | Optical Imaging | 2 | 2018 | 61 | 0.130 |
Why?
| | Bacteriophages | 1 | 2018 | 95 | 0.130 |
Why?
| | Severity of Illness Index | 6 | 2021 | 2831 | 0.130 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 60 | 0.130 |
Why?
| | Credentialing | 1 | 2017 | 17 | 0.130 |
Why?
| | Cattle | 3 | 2018 | 981 | 0.130 |
Why?
| | Quality of Life | 2 | 2024 | 2868 | 0.130 |
Why?
| | Research | 1 | 2020 | 445 | 0.130 |
Why?
| | MicroRNAs | 2 | 2015 | 697 | 0.130 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2016 | 5 | 0.130 |
Why?
| | Immunoassay | 1 | 2017 | 113 | 0.130 |
Why?
| | Leiomyoma | 1 | 2017 | 77 | 0.130 |
Why?
| | Patient Discharge | 1 | 2023 | 896 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 658 | 0.130 |
Why?
| | Chemoprevention | 2 | 2014 | 92 | 0.120 |
Why?
| | Bariatric Surgery | 1 | 2019 | 214 | 0.120 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2016 | 80 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2018 | 1318 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 117 | 0.120 |
Why?
| | Global Health | 1 | 2018 | 386 | 0.120 |
Why?
| | Surveys and Questionnaires | 8 | 2024 | 5749 | 0.120 |
Why?
| | Physicians | 1 | 2024 | 897 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 57 | 0.120 |
Why?
| | Metals | 3 | 2023 | 137 | 0.120 |
Why?
| | Teaching | 1 | 2017 | 226 | 0.120 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 205 | 0.120 |
Why?
| | Intestinal Fistula | 1 | 2014 | 17 | 0.110 |
Why?
| | Administration, Rectal | 2 | 2024 | 11 | 0.110 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 183 | 0.110 |
Why?
| | Cryosurgery | 1 | 2015 | 59 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 24 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 781 | 0.110 |
Why?
| | Goblet Cells | 1 | 2013 | 22 | 0.110 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1235 | 0.110 |
Why?
| | Prosthesis Failure | 1 | 2014 | 116 | 0.110 |
Why?
| | Suture Techniques | 1 | 2014 | 122 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 401 | 0.110 |
Why?
| | Patient Participation | 1 | 2017 | 416 | 0.100 |
Why?
| | Primary Health Care | 2 | 2022 | 1714 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 487 | 0.100 |
Why?
| | Propensity Score | 1 | 2015 | 288 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2006 | 843 | 0.100 |
Why?
| | Biomarkers | 5 | 2025 | 4158 | 0.100 |
Why?
| | Light | 2 | 2013 | 382 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 39 | 0.100 |
Why?
| | Jejunum | 1 | 2012 | 31 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2006 | 1059 | 0.100 |
Why?
| | Equipment Design | 3 | 2021 | 522 | 0.100 |
Why?
| | Mediastinum | 1 | 2012 | 25 | 0.100 |
Why?
| | Young Adult | 8 | 2025 | 13126 | 0.090 |
Why?
| | Decision Making | 3 | 2023 | 896 | 0.090 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2016 | 351 | 0.090 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 47 | 0.090 |
Why?
| | Peptides | 1 | 2017 | 980 | 0.090 |
Why?
| | Abdomen | 1 | 2012 | 125 | 0.090 |
Why?
| | Injections, Intravenous | 1 | 2011 | 205 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1260 | 0.090 |
Why?
| | Patient Selection | 1 | 2015 | 689 | 0.090 |
Why?
| | Adrenal Glands | 1 | 2011 | 77 | 0.090 |
Why?
| | Guidelines as Topic | 1 | 2012 | 276 | 0.090 |
Why?
| | Intestines | 1 | 2013 | 359 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1108 | 0.080 |
Why?
| | Esophagitis | 2 | 2007 | 67 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1274 | 0.080 |
Why?
| | Veterans | 1 | 2021 | 1457 | 0.080 |
Why?
| | Adolescent | 8 | 2025 | 21463 | 0.080 |
Why?
| | Esophageal pH Monitoring | 1 | 2009 | 23 | 0.080 |
Why?
| | Software | 1 | 2014 | 663 | 0.080 |
Why?
| | North America | 2 | 2020 | 313 | 0.080 |
Why?
| | Body Mass Index | 3 | 2013 | 2364 | 0.080 |
Why?
| | Gastric Acid | 1 | 2009 | 14 | 0.080 |
Why?
| | Antacids | 1 | 2009 | 16 | 0.080 |
Why?
| | Remission Induction | 1 | 2009 | 287 | 0.070 |
Why?
| | National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2017 | 10 | 0.070 |
Why?
| | Patient Care Planning | 1 | 2009 | 154 | 0.070 |
Why?
| | Hematoporphyrin Photoradiation | 1 | 2007 | 1 | 0.070 |
Why?
| | Colonography, Computed Tomographic | 1 | 2007 | 8 | 0.070 |
Why?
| | Gastric Fundus | 1 | 2007 | 3 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 806 | 0.070 |
Why?
| | Capsule Endoscopy | 1 | 2007 | 18 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1043 | 0.060 |
Why?
| | Plasmapheresis | 1 | 2006 | 24 | 0.060 |
Why?
| | Gastritis | 1 | 2007 | 108 | 0.060 |
Why?
| | Dairying | 1 | 2005 | 7 | 0.060 |
Why?
| | CDX2 Transcription Factor | 1 | 2025 | 1 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2007 | 267 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 8 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 64 | 0.060 |
Why?
| | Image-Guided Biopsy | 2 | 2015 | 39 | 0.050 |
Why?
| | DNA Primers | 1 | 2005 | 513 | 0.050 |
Why?
| | Virulence | 1 | 2005 | 265 | 0.050 |
Why?
| | Seasons | 1 | 2006 | 544 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 838 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2005 | 336 | 0.050 |
Why?
| | Animals | 5 | 2023 | 36768 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 167 | 0.050 |
Why?
| | United Kingdom | 1 | 2023 | 315 | 0.050 |
Why?
| | Tumor Burden | 2 | 2015 | 309 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 522 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2006 | 495 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1938 | 0.050 |
Why?
| | Appendectomy | 1 | 2022 | 79 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 244 | 0.050 |
Why?
| | Renal Dialysis | 1 | 2006 | 434 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 217 | 0.050 |
Why?
| | Feces | 1 | 2005 | 479 | 0.050 |
Why?
| | Technology | 1 | 2022 | 96 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2024 | 324 | 0.050 |
Why?
| | Colonic Diseases | 2 | 2014 | 33 | 0.050 |
Why?
| | Osteogenesis | 1 | 2023 | 187 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2024 | 318 | 0.040 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 74 | 0.040 |
Why?
| | Lifting | 1 | 2020 | 4 | 0.040 |
Why?
| | Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 5 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 172 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5417 | 0.040 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 21 | 0.040 |
Why?
| | Cough | 1 | 2021 | 121 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 556 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1981 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 430 | 0.040 |
Why?
| | Granuloma | 1 | 2020 | 91 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 52 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2021 | 125 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 226 | 0.040 |
Why?
| | Pilot Projects | 3 | 2011 | 1697 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 544 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1208 | 0.040 |
Why?
| | Rural Population | 1 | 2023 | 561 | 0.040 |
Why?
| | Cross-Over Studies | 2 | 2012 | 560 | 0.040 |
Why?
| | Myoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| | Podoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 518 | 0.040 |
Why?
| | Coloring Agents | 1 | 2018 | 86 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2021 | 403 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2018 | 152 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 800 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1455 | 0.040 |
Why?
| | Cyst Fluid | 1 | 2018 | 25 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2018 | 345 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2020 | 316 | 0.040 |
Why?
| | Abdominal Pain | 1 | 2019 | 145 | 0.040 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2018 | 52 | 0.040 |
Why?
| | Communication | 1 | 2024 | 869 | 0.040 |
Why?
| | Hospitals, University | 1 | 2018 | 180 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 152 | 0.030 |
Why?
| | User-Computer Interface | 1 | 2018 | 157 | 0.030 |
Why?
| | Genome, Viral | 1 | 2018 | 144 | 0.030 |
Why?
| | Granular Cell Tumor | 1 | 2017 | 7 | 0.030 |
Why?
| | Lipoma | 1 | 2017 | 16 | 0.030 |
Why?
| | Review Literature as Topic | 1 | 2017 | 74 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2847 | 0.030 |
Why?
| | Cancer Pain | 1 | 2017 | 28 | 0.030 |
Why?
| | Choristoma | 1 | 2017 | 21 | 0.030 |
Why?
| | Choledochal Cyst | 1 | 2016 | 19 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 400 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 452 | 0.030 |
Why?
| | Gastroscopes | 1 | 2016 | 3 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2831 | 0.030 |
Why?
| | Biliary Tract Neoplasms | 1 | 2016 | 30 | 0.030 |
Why?
| | Duodenoscopes | 1 | 2016 | 7 | 0.030 |
Why?
| | Nerve Block | 1 | 2017 | 74 | 0.030 |
Why?
| | Embolism, Air | 1 | 2016 | 14 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 991 | 0.030 |
Why?
| | Exons | 1 | 2017 | 349 | 0.030 |
Why?
| | Cholangitis, Sclerosing | 1 | 2016 | 75 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 644 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 343 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2473 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3399 | 0.030 |
Why?
| | Algorithms | 2 | 2017 | 1686 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11069 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 728 | 0.030 |
Why?
| | Bone and Bones | 1 | 2017 | 316 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1036 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 455 | 0.030 |
Why?
| | Child | 3 | 2021 | 21968 | 0.030 |
Why?
| | Equipment Failure | 1 | 2014 | 108 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2548 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2021 | 649 | 0.030 |
Why?
| | Proteome | 1 | 2018 | 472 | 0.030 |
Why?
| | Pain | 1 | 2019 | 755 | 0.030 |
Why?
| | Pathology | 1 | 2013 | 24 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 171 | 0.030 |
Why?
| | Autoimmune Diseases | 1 | 2017 | 459 | 0.030 |
Why?
| | Community Health Centers | 1 | 2013 | 58 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1980 | 0.030 |
Why?
| | Mice | 2 | 2023 | 17731 | 0.030 |
Why?
| | Community Health Services | 1 | 2014 | 228 | 0.030 |
Why?
| | Color | 1 | 2013 | 77 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3199 | 0.020 |
Why?
| | Neoplasm Grading | 1 | 2013 | 306 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1347 | 0.020 |
Why?
| | Gastroscopy | 1 | 2011 | 19 | 0.020 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 47 | 0.020 |
Why?
| | Digestive System Neoplasms | 1 | 2011 | 9 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 328 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 116 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2013 | 497 | 0.020 |
Why?
| | Risk | 1 | 2013 | 904 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2999 | 0.020 |
Why?
| | Life Style | 1 | 2013 | 484 | 0.020 |
Why?
| | Genetic Markers | 1 | 2011 | 344 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3953 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4194 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 973 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 845 | 0.020 |
Why?
| | Overweight | 1 | 2013 | 557 | 0.020 |
Why?
| | Geography | 1 | 2008 | 197 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 564 | 0.020 |
Why?
| | Diagnostic Equipment | 1 | 2007 | 4 | 0.020 |
Why?
| | Colorado | 1 | 2018 | 4491 | 0.020 |
Why?
| | Motor Activity | 1 | 2013 | 719 | 0.020 |
Why?
| | Helicobacter Infections | 1 | 2007 | 32 | 0.020 |
Why?
| | Selenium | 1 | 2007 | 39 | 0.020 |
Why?
| | Fraud | 1 | 2007 | 9 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2007 | 42 | 0.020 |
Why?
| | Electrocoagulation | 1 | 2007 | 40 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2007 | 55 | 0.020 |
Why?
| | Quality Control | 1 | 2007 | 171 | 0.020 |
Why?
| | Laser Coagulation | 1 | 2007 | 68 | 0.020 |
Why?
| | Risk Management | 1 | 2007 | 91 | 0.020 |
Why?
| | Capillaries | 1 | 2007 | 108 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5744 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1731 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2007 | 330 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 752 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2007 | 331 | 0.010 |
Why?
| | Monocytes | 1 | 2007 | 561 | 0.010 |
Why?
| | Health Policy | 1 | 2007 | 387 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9442 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2129 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2007 | 1281 | 0.010 |
Why?
| | Comorbidity | 1 | 2007 | 1611 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2603 | 0.010 |
Why?
| | Neutrophils | 1 | 2007 | 1234 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1633 | 0.010 |
Why?
| | Diet | 1 | 2007 | 1273 | 0.010 |
Why?
|
|
Wani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|